Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Early Glasses Study: Can Early Glasses Prevent the Development of Amblyopia in Children With High Refractive Errors at Age One

NCT04740593 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04740593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Early Glasses Study: Can Early Glasses Prevent the Development of Amblyopia in Children With High Refractive Errors at Age One
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 10, 2021
Completion date
March 31, 2026
Enrollment
601 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amblyopia, refractive errors